Affinity Asset Advisors, LLC Q4 2020 Filing
Filed February 12, 2021
Portfolio Value
$188.7B
Holdings
61
Report Date
Q4 2020
Filing Type
13F-HR
All Holdings (61 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | —EIDOS THERAPEUTICS INC | 225,000 | $29.6B | 15.69% | |
| 2 | SPYSPDR S&P 500 ETF TRUST TRUST | 40,000 | $15.0B | 7.93% | Put |
| 3 | —CURIS INC | 1,450,000 | $11.9B | 6.29% | |
| 4 | BBIOBRIDGEBIO PHARMA INC | 155,000 | $11.0B | 5.84% | |
| 5 | KURAKURA ONCOLOGY INC | 260,000 | $8.5B | 4.50% | |
| 6 | —VINCERA PHARMA INC | 403,000 | $8.4B | 4.47% | |
| 7 | RCKTROCKET PHARMACEUTICALS INC | 105,000 | $5.8B | 3.05% | |
| 8 | XLRNACCELERON PHARMA INC | 45,000 | $5.8B | 3.05% | |
| 9 | OCULOCULAR THERAPEUTIX INC | 220,000 | $4.6B | 2.41% | |
| 10 | CERE1EURCEREVEL THERAPEUTICS HOLDINGS I | 270,000 | $4.5B | 2.37% | |
| 11 | STROSUTRO BIOPHARMA INC | 200,000 | $4.3B | 2.30% | |
| 12 | TVTX 2.5 09/15/25RETROPHIN INC | 4,000,000 | $4.0B | 2.14% | |
| 13 | ARKGARK ETF TR | 40,000 | $3.7B | 1.98% | Put |
| 14 | IMVTIMMUNOVANT INC | 75,000 | $3.5B | 1.84% | |
| 15 | SNDXSYNDAX PHARMACEUTICALS INC | 150,500 | $3.3B | 1.77% | Call |
| 16 | HZNPHORIZON THERAPEUTICS PLC | 45,000 | $3.3B | 1.74% | |
| 17 | —ARYA SCIENCES ACQUISITION CO | 300,000 | $3.3B | 1.73% | |
| 18 | —LIFESCI ACQUISITION II CORP | 300,000 | $3.2B | 1.70% | |
| 19 | —ZYMEWORKS INC | 65,000 | $3.1B | 1.63% | |
| 20 | AXSMAXSOME THERAPEUTICS INC | 35,000 | $2.9B | 1.51% | Call |
| 21 | —HEALTH SCIENCES ACQUISITIONS CORP 2 | 200,000 | $2.6B | 1.36% | |
| 22 | 290ACHINOOK THERAPEUTICS INC | 150,000 | $2.4B | 1.26% | |
| 23 | VRTXVERTEX PHARMACEUTICALS INC | 10,000 | $2.4B | 1.25% | |
| 24 | MORFMORPHIC HOLDING INC | 67,500 | $2.3B | 1.20% | |
| 25 | MREOMEREO BIOPHARMA GROUP PLC | 625,000 | $2.2B | 1.19% | |
| 26 | ATNXEURATHENEX INC | 200,000 | $2.2B | 1.17% | |
| 27 | MRTXEURMIRATI THERAPEUTICS INC | 10,000 | $2.2B | 1.16% | |
| 28 | GBTUSDGLOBAL BLOOD THERAPEUTICS INC | 50,000 | $2.2B | 1.15% | |
| 29 | LPTXEURLEAP THERAPEUTICS INC | 904,600 | $2.0B | 1.08% | |
| 30 | SLDBSOLID BIOSCIENCES INC | 250,000 | $1.9B | 1.00% | Call |
| 31 | ASNDASCENDIS PHARMA A/S | 10,000 | $1.7B | 0.88% | |
| 32 | MGTXMEIRAGTX HOLDINGS PLC | 100,000 | $1.5B | 0.80% | |
| 33 | —LONGVIEW ACQUISITION CORP | 75,000 | $1.5B | 0.79% | |
| 34 | CYTKCYTOKINETICS INC | 70,000 | $1.5B | 0.77% | |
| 35 | LUNGPULMONX CORPORATION | 20,000 | $1.4B | 0.73% | |
| 36 | —MERSANA THERAPEUTICS INC | 50,000 | $1.3B | 0.71% | |
| 37 | TCE2CELLDEX THERAPEUTICS INC | 75,000 | $1.3B | 0.70% | |
| 38 | —PANDION THERAPEUTICS INC | 80,000 | $1.2B | 0.63% | |
| 39 | —BCTG ACQUISITION CORP | 100,000 | $1.1B | 0.61% | |
| 40 | —VESPER HEALTHCARE ACQUISITION CORP | 100,000 | $1.1B | 0.60% | |
| 41 | —CYCLACEL PHARMACEUTICALS INC | 117,545 | $918.0M | 0.49% | |
| 42 | BYSIBEYONDSPRING INC | 75,000 | $915.0M | 0.48% | |
| 43 | IOVAIOVANCE BIOTHERAPEUTICS INC | 19,600 | $909.0M | 0.48% | |
| 44 | —DICERNA PHARMACEUTICALS INC | 40,000 | $881.0M | 0.47% | |
| 45 | NARIUSDINARI MEDICAL INC | 10,000 | $873.0M | 0.46% | |
| 46 | KALVKALVISTA PHARMACEUTICALS INC | 45,000 | $855.0M | 0.45% | |
| 47 | PCVXVAXCYTE INC | 30,000 | $797.0M | 0.42% | |
| 48 | —CHARDAN HEALTHCARE ACQUISITION 2 CORP | 75,000 | $794.0M | 0.42% | |
| 49 | IMTXIMMATICS N.V | 242,855 | $699.0M | 0.37% | |
| 50 | AXONEURSIO GENE THERAPIES INC | 250,000 | $695.0M | 0.37% | |
| 51 | ALDXALDEYRA THERAPEUTICS INC | 100,000 | $686.0M | 0.36% | |
| 52 | CCCCC4 THERAPEUTICS INC | 20,000 | $663.0M | 0.35% | |
| 53 | —VINCERA PHARMA INC | 190,000 | $627.0M | 0.33% | |
| 54 | LYRALYRA THERAPEUTICS INC | 50,000 | $570.0M | 0.30% | |
| 55 | OMGBPOUTSET MEDICAL INC | 10,000 | $568.0M | 0.30% | |
| 56 | MDGLMADRIGAL PHARMACEUTICALS INC | 5,000 | $556.0M | 0.29% | |
| 57 | CRSPCRISPR THERAPEUTICS AG | 3,500 | $536.0M | 0.28% | |
| 58 | —CEREVEL THERAPEUTICS HOLDINGS I | 72,466 | $409.0M | 0.22% | |
| 59 | VXRTVAXART INC | 25,000 | $143.0M | 0.08% | Put |
| 60 | —VESPER HEALTHCARE ACQUISITION CORP | 33,333 | $88.0M | 0.05% | |
| 61 | —ZYNERBA PHARMACEUTICALS INC | 13,285 | $44.0M | 0.02% |